How would you treat an elderly female with residual TNBC following surgery and neoadjuvant Carboplatin and Paclitaxel?

I think there will be some differing opinions on this. There are a number of things I would factor in assuming the patient has enough life expectancy where the breast cancer is the main mortality risk.

1) Data from carbo/taxane neoadjuvant trials (Sharma et al CCR 2018) and others suggest RCB1 patie...